48,830
edits
(→IHC: more) |
|||
Line 505: | Line 505: | ||
===IHC=== | ===IHC=== | ||
Thyroid versus something else: | |||
*Thyroglobulin +ve. | *Thyroglobulin +ve. | ||
*TTF-1 (thyroid transcription factor-1) +ve. | *TTF-1 (thyroid transcription factor-1) +ve. | ||
*CD15 +ve. ( | *CD15 +ve.{{fact}} | ||
PTC versus benign:<ref>{{Cite journal | last1 = Mataraci | first1 = EA. | last2 = Ozgüven | first2 = BY. | last3 = Kabukçuoglu | first3 = F. | title = Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions. | journal = Pol J Pathol | volume = 63 | issue = 1 | pages = 58-64 | month = Mar | year = 2012 | doi = | PMID = 22535608 }}</ref> | |||
*HBME-1 +ve (strong, diffuse). | |||
*CK19 +ve (strong, diffuse). | |||
*Galectin-3 +ve (strong, diffuse). | |||
===Molecular=== | ===Molecular=== |
edits